These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38798123)

  • 21. Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
    RECOVERY Collaborative Group
    Lancet Respir Med; 2021 Dec; 9(12):1419-1426. PubMed ID: 34672950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proactive anti-inflammatory therapy with colchicine in the treatment of advanced stages of new coronavirus infection. The first results of the COLORIT study.
    Mareev VY; Orlova YA; Plisyk AG; Pavlikova EP; Akopyan ZA; Matskeplishvili ST; Malakhov PS; Krasnova TN; Seredenina EM; Potapenko AV; Agapov MA; Asratyan DA; Dyachuk LI; Samokhodskaya LM; Mershina ЕА; Sinitsyn VE; Pakhomov PV; Zhdanova EA; Mareev YV; Begrambekova YL; Kamalov АА
    Kardiologiia; 2021 Mar; 61(2):15-27. PubMed ID: 33734043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colchicine reduces the activation of NLRP3 inflammasome in COVID-19 patients.
    Amaral NB; Rodrigues TS; Giannini MC; Lopes MI; Bonjorno LP; Menezes PISO; Dib SM; Gigante SLG; Benatti MN; Rezek UC; Emrich-Filho LL; Sousa BA; Almeida SCL; Luppino-Assad R; Veras FP; Schneider AH; Leiria LOS; Cunha LD; Alves-Filho JC; Cunha TM; Arruda E; Miranda CH; Pazin-Filho A; Auxiliadora-Martins M; Borges MC; Fonseca BAL; Bollela VR; Del-Ben CM; Cunha FQ; Santana RC; Vilar FC; Zamboni DS; Louzada-Junior P; Oliveira RDR
    Inflamm Res; 2023 May; 72(5):895-899. PubMed ID: 36917217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol.
    Marietta M; Vandelli P; Mighali P; Vicini R; Coluccio V; D'Amico R;
    Trials; 2020 Jun; 21(1):574. PubMed ID: 32586394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential Role of Colchicine in Combating COVID-19 Cytokine Storm and Its Ability to Inhibit Protease Enzyme of SARS-CoV-2 as Conferred by Molecular Docking Analysis.
    Kamel NA; Ismail NSM; Yahia IS; Aboshanab KM
    Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors).
    Bonifácio LP; Ramacciotti E; Agati LB; Vilar FC; Silva ACTD; Louzada Júnior P; Fonseca BALD; Souza HCC; Oliveira CCC; Aguiar VCR; Quadros CAA; Dusilek C; Itinose K; Risson R; Ferreira LRR; Lopes RD; Kallas EG; Bellissimo-Rodrigues F
    Rev Soc Bras Med Trop; 2023; 56():e0565. PubMed ID: 37075454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adding Colchicine to the Antiretroviral Medication - Lopinavir/Ritonavir (Kaletra) in Hospitalized Patients with Non-Severe Covid-19 Pneumonia: A Structured Summary of a Study Protocol for a Randomized Controlled Trial.
    Dalili N; Kashefizadeh A; Nafar M; Poorrezagholi F; Firouzan A; Samadian F; Samavat S; Ziaie S; Fatemizadeh S
    Trials; 2020 Jun; 21(1):489. PubMed ID: 32503620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.
    Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A;
    Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of colchicine on mortality outcome and duration of hospital stay in patients with COVID-19: A meta-analysis of randomized trials.
    Kow CS; Lee LH; Ramachandram DS; Hasan SS; Ming LC; Goh HP
    Immun Inflamm Dis; 2022 Feb; 10(2):255-264. PubMed ID: 34970856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19 in patients with familial Mediterranean fever treated with colchicine: case based review.
    Nas K; Eryilmaz N; Geyik MF; Altaş A
    Rheumatol Int; 2021 Apr; 41(4):811-817. PubMed ID: 33611657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment with COLchicine in hospitalized patients affected by COVID-19: The COLVID-19 trial.
    Perricone C; Scarsi M; Brucato A; Pisano P; Pigatto E; Becattini C; Cingolani A; Tiso F; Prota R; Tomasoni LR; Cutolo M; Tardella M; Rozza D; Zerbino C; Andreoni M; Poletti V; Bartoloni E; Gerli R;
    Eur J Intern Med; 2023 Jan; 107():30-36. PubMed ID: 36396522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colchicine and mortality in patients with coronavirus disease 2019 (COVID-19) pneumonia: A systematic review, meta-analysis, and meta-regression.
    Nawangsih EN; Kusmala YY; Rakhmat II; Handayani DR; Juliastuti H; Wibowo A; Lim MA; Pranata R
    Int Immunopharmacol; 2021 Jul; 96():107723. PubMed ID: 34162130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotics for the treatment of COVID-19.
    Popp M; Stegemann M; Riemer M; Metzendorf MI; Romero CS; Mikolajewska A; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD015025. PubMed ID: 34679203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of colchicine in the management of COVID-19: a Meta-analysis.
    Elshiwy K; Amin GEE; Farres MN; Samir R; Allam MF
    BMC Pulm Med; 2024 Apr; 24(1):190. PubMed ID: 38641775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colchicine and SARS-CoV-2: Management of the hyperinflammatory state.
    Vitiello A; Ferrara F
    Respir Med; 2021 Mar; 178():106322. PubMed ID: 33550151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colchicine treatment can improve outcomes of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
    Hariyanto TI; Halim DA; Jodhinata C; Yanto TA; Kurniawan A
    Clin Exp Pharmacol Physiol; 2021 Jun; 48(6):823-830. PubMed ID: 33719081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The COVIRL002 Trial-Tocilizumab for management of severe, non-critical COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial.
    Cotter A; Wallace D; McCarthy C; Feeney E; O'Neill L; Stack J; McCarthy G; Hussain R; Alvarez Barco E; Doran P; Mallon P
    Trials; 2020 Sep; 21(1):758. PubMed ID: 32883328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial.
    Tardif JC; Bouabdallaoui N; L'Allier PL; Gaudet D; Shah B; Pillinger MH; Lopez-Sendon J; da Luz P; Verret L; Audet S; Dupuis J; Denault A; Pelletier M; Tessier PA; Samson S; Fortin D; Tardif JD; Busseuil D; Goulet E; Lacoste C; Dubois A; Joshi AY; Waters DD; Hsue P; Lepor NE; Lesage F; Sainturet N; Roy-Clavel E; Bassevitch Z; Orfanos A; Stamatescu G; Grégoire JC; Busque L; Lavallée C; Hétu PO; Paquette JS; Deftereos SG; Levesque S; Cossette M; Nozza A; Chabot-Blanchet M; Dubé MP; Guertin MC; Boivin G;
    Lancet Respir Med; 2021 Aug; 9(8):924-932. PubMed ID: 34051877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.